Literature DB >> 31128010

Correlations of coagulation indexes and inflammatory changes with the prognosis of lung cancer complicated with thromboembolic disease.

Minfeng Zhu1, Yi Dai, Feng Gao, Chunming Xu, Lixiu Chen, Yun Xu, Wenxia Qian.   

Abstract

PURPOSE: To investigate the correlations of coagulation indexes and inflammatory changes with the prognosis of lung cancer (LC) patients complicated with thromboembolic (TE) disease.
METHODS: A total of 84 LC patients complicated with TE disease admitted to hospital from January 2010 to January 2016 were enrolled in this study and their clinical data were retrospectively analyzed. A 2-year post-treatment follow-up was carried out. According to the prognosis, patients were divided into 2 groups as dead group (n=25) and alive group (n=59). The coagulation indexes and inflammatory factor levels before low-molecular weight heparin (LMWH) treatment and on the 1st, 3rd, and 7th day after treatment were compared between the two groups. Their relations with the prognosis of patients were analyzed using Pearson method.
RESULTS: No statistically significant difference was found in the prothrombin time (PT), levels of Fibrinogen (FIB), D-Dimer (D-D), Interleukin-6 (IL-6) and Procalcitonin (PCT), and activated partial thromboplastin time (APTT) before treatment between the two groups (p>0.05). The PT and levels of FIB, D-D, IL-6, and PCT on the 1st, 3rd, and 7th day after treatment were significantly increased in the dead group compared to those in the alive group, while the APTT was remarkably shortened. Moreover, the PT was gradually prolonged and FIB, D-D, IL-6 and PCT levels were increased in the dead group , but the APTT was gradually shortened over time (p<0.05). The poor prognosis of LC patients complicated with TE disease was positively correlated with PT, FIB, D-D, IL-6 and PCT, but negatively correlated with APTT (p<0.05).
CONCLUSION: The poor prognosis of LC complicated with TE disease has positive correlations with PT, FIB, D-D, IL-6 and PCT, and a negative association with APTT, providing a certain reference as a prognostic value in the diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31128010

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  5 in total

1.  Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT).

Authors:  Lin Zhang; Juan Ye; Qiuyun Luo; Miaohuan Kuang; Minjie Mao; Shuqin Dai; Xueping Wang
Journal:  Cancer Manag Res       Date:  2020-07-03       Impact factor: 3.989

2.  Prothrombin time (PT) and CEA as prognostic predictive biomarkers for postoperative recurrence after curative resection in patients with stage I-III colorectal cancer: a retrospective cohort study.

Authors:  Lulu Ma; Wenya Li; Ningquan Liu; Zhijie Ding; Jianchun Cai; Yiyao Zhang
Journal:  Updates Surg       Date:  2022-03-24

3.  Golden berry 4β-hydroxywithanolide E prevents tumor necrosis factor α-induced procoagulant activity with enhanced cytotoxicity against human lung cancer cells.

Authors:  Kan-Yen Hsieh; Ju-Ying Tsai; Ya-Han Lin; Fang-Rong Chang; Hui-Chun Wang; Chin-Chung Wu
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

4.  Relationship between Hypercoagulable State and Circulating Tumor Cells in Peripheral Blood, Pathological Characteristics, and Prognosis of Lung Cancer Patients.

Authors:  Yanhua Jiao; Liling Guo; Linqian Wu; Tongshan Hu
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-21       Impact factor: 2.629

5.  Association between short-term heart rate variability and blood coagulation in patients with breast cancer.

Authors:  Lingling Wang; Jingfeng Wang; Peng Li; Xiangzhi Wang; Shuang Wu; Bo Shi
Journal:  Sci Rep       Date:  2021-07-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.